Logo

American Heart Association

Jason Ta

Is this you? Login and claim your profile. Then, you can add your biography and additional Information.

Showing 1 Abstract.

Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control

Meeting name: Scientific Sessions 2025 , 2025 , New Orleans, Louisiana

Authors: Win Zin , Aboaid Hazem , Nguyen Kevin , Myat Yin , Chu Matthew , Mohib Khadija , Macias Aziel , Htwe Khaing Khaing , Thein Kyaw , Hussain Abbas , Srinivasmurthy Ramaditya , Hattin Riccesha , Jones Daniel , Nanda Rishi , Ta Jason , Chu Timothy , Tun Tin

Keywords: Cardio-oncology, QT interval, Heart failure, Ejection fraction, Quality of life